Table 4

Predictive value of PROMIS self-efficacy on HRQoL in patients from the Almenara Lupus Cohort

Physical functioningRole physicalBodily painGeneral health
B (SE)p valueB (SE)p valueB (SE)p valueB (SE)p value
Self-efficacy for managing daily activities0.34 (0.16)0.0360.84 (0.31)0.0070.51 (0.16)0.0010.47 (0.14)0.001
Self-efficacy for managing symptoms0.26 (0.13)0.0530.80 (0.27)0.0030.47 (0.14)<0.0010.32 (0.12)0.006
Self-efficacy for managing medications and treatment*0.15 (0.14)0.2750.71 (0.29)0.0150.28 (0.14)0.0450.22 (0.12)0.072
Self-efficacy for managing emotions0.16 (0.11)0.1770.45 (0.28)0.1080.38 (0.14)0.0080.21 (0.11)0.066
Self-efficacy for managing social interactions0.25 (0.11)0.0300.65 (0.26)0.0120.41 (0.14)0.0020.33 (0.10)0.002
General self-efficacy0.18 (0.10)0.0810.62 (0.21)0.0030.32 (0.11)0.0030.54 (0.06)0.007
  • Adjusted for age at diagnosis, gender, socioeconomic status, SLEDAI-2K, SLICC/American College of Rheumatology Damage Index, disease duration at baseline, prednisone daily dose, antimalarial and immunosuppressive drugs use and the same domain in the previous visit.

  • Values in bold are those that are statistically significant.

  • *One patient was excluded as she was not taking any medication during her follow-up.

  • HRQoL, health-related quality of life; PROMIS, Patient-Reported Outcomes Measurement Information System; SLEDAI-2K, Systemic Lupus Erythematosus Disease Activity Index 2K; SLICC, Systemic Lupus International Collaborating Clinics.